2010 annual financial data
Supernus Pharmaceuticals 2010 Net income growth
Direct answer
Net income growth was -8,461.52%.
Operating income was -40,123,000 USD and net income was -38,463,000 USD.
Operating cash flow was -32,544,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 106,000 USD
- Operating income
- -40,123,000 USD
- Net income
- -38,463,000 USD
- Operating cash flow
- -32,544,000 USD